Improved Screening Rate After the Implementation of Immediate Postpartum Diabetes Screening in a Hybrid Community-Teaching Hospital [ID 948]

INTRODUCTION: Recently, the American College of Obstetricians and Gynecologists endorsed immediate postpartum diabetes screening, ie, screening on postpartum day 1 or 2, as it has a similar diagnostic value to screening at 4–12 weeks postpartum but achieves a higher completion rate. Before implementing universal immediate screening in December 2023, our institution's postpartum diabetes screening rate was 14%. Our objective was to assess the immediate postpartum diabetes screening rate and factors associated with screening. METHODS: We conducted a retrospective chart review of patients with gestational diabetes (GDM) who delivered at our institution from December 1, 2023, to June 30, 2024. We queried the electronic medical record for patient demographics, practice type, medical history, delivery information, and immediate diabetes screening results. A logistic regression identified factors associated with screening. RESULTS: Among 149 patients with GDM, 63.7% (n=95) underwent immediate screening, with 45.2% (n=43) screening positive. Hospital clinic patients and those who had a cesarean delivery were three times more likely to get screened (odds ratio [OR] 3.01, 95% CI, 1.18–7.66; OR 3.09, 95% CI, 1.35–7.09), whereas those with a post-vaginal delivery length of stay of less than 2 days were less likely to complete screening (OR 0.103; 95% CI, 0.038–0.277). Type of GDM, diabetes control, neonatal weight, comorbidities, age, body mass index, race, ethnicity, and insurance type did not affect the screening rate. CONCLUSIONS/IMPLICATIONS: Immediate postpartum diabetes screening improved the screening rate but was affected by the practice type, delivery mode, and length of stay for vaginal deliveries. We are currently exploring attitudes and barriers to immediate screening among physicians and patients.